Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Nicarbazin** is a synthetic veterinary anticoccidial used primarily in medicated poultry feed to prevent intestinal and caecal coccidiosis caused by *Eimeria* species in broiler chickens. It is an equimolar physical-chemical complex of 4,4′-dinitrocarbanilide and 2-hydroxy-4,6-dimethylpyrimidine. Its precise molecular target has not been definitively established, but it is understood to disrupt *Eimeria* mitochondrial energy metabolism and parasite replication, with pronounced activity against later intracellular schizont and merozoite stages. Nicarbazin is also used in avian contraceptive bait products for pigeon population management, where it reduces egg hatchability by disrupting egg fertilization-related processes. ([pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/Nicarbazin))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nicarbazin.